Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James A Tarbox, MD
Texas Tech University Health Sciences Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Diego Olavarria Bernal, MDJacob Nichols, MDJames A Tarbox, MDJoshua A Peterson, MDKaKa L Adams, MDMaireigh McCullough, MDMiriam Paz Sierra, MDNattanicha Chaisrimaneepan, MDNicole Welch, MDSafa Mohamed, MDSierra Sullivan, MDWatsachon Pangkanon, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Feb 2024
- Primary completion
- 31 Jul 2026
- Completion
- 31 Dec 2026
- Last update posted
- 1 May 2025
- Registered enrollment
- 380
- Registry id
- NCT06303128
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.